Literature DB >> 16751136

Ex vivo expansion of stem cells: defining optimum conditions using various cytokines.

Azza A Mohamed1, Azza M Ibrahim, Manal W El-Masry, Iman M Mansour, Mervat A Khroshied, Heba M Gouda, Raafat M Riad.   

Abstract

With the increasing information on the number, quality, and characteristics of hematopoietic stem cells (HSC) in umbilical cord and placental blood, this material has been found to be efficacious as an alternative source of HSC for transplantation in children. In this study, we sought to define the optimal conditions for ex vivo expansion of cord blood (CB) stem cells. These conditions include: the combinations and concentrations of hematopoietic growth factors (stem cell factor [SCF], granulocyte-macrophage colony-stimulating factor [GM-CSF], interleukin [IL]-3, thrombopoietin [Tpo], IL-6 and Fms-like tyrosine kinase 3 ligand [Flt-3L]), the duration of culture, and the effect of serum supplementation. In this study, 2 protocols were applied for ex vivo expansion of CB stem cells. In protocol I, 20 CB samples were expanded in a static, serum-added, liquid culture for 7 and 11 days using 5 cytokine cocktails. In protocol II, 10 CB samples were expanded for 7 days using cytokines of cocktail 1, with and without IL-6 and Flt-3L, in serum-added and serum-free culture media. This protocol was intended to verify the effect of IL-6, Flt-3L, and the role of serum supplementation in short-term liquid culture. From the present study, it can be concluded that cocktail 1 is the cocktail of choice for ex vivo expansion of CB stem cells in serum-free, liquid culture expanded for 7 days. We can also conclude that culture expanded for 7 days is better than 11 days, as the fold expansion of CD34+ cells was not significantly increased or even decreased in some of the cocktails used. Moreover, the percent of CD95+ cells (apoptotic cells) was significantly increased on day 11 compared to day 7 in the cocktails tested.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751136     DOI: 10.1532/LH96.05033

Source DB:  PubMed          Journal:  Lab Hematol        ISSN: 1080-2924


  12 in total

1.  Microliter-bioreactor array with buoyancy-driven stirring for human hematopoietic stem cell culture.

Authors:  Camilla Luni; Hope C Feldman; Michela Pozzobon; Paolo De Coppi; Carl D Meinhart; Nicola Elvassore
Journal:  Biomicrofluidics       Date:  2010-08-11       Impact factor: 2.800

2.  Expansion of human hematopoietic stem cells for transplantation: trends and perspectives.

Authors:  Hera Andrade-Zaldívar; Leticia Santos; Antonio De León Rodríguez
Journal:  Cytotechnology       Date:  2008-03-29       Impact factor: 2.058

Review 3.  Engineering cord blood to improve engraftment after cord blood transplant.

Authors:  Rohtesh S Mehta; Hema Dave; Catherine M Bollard; Elizabeth J Shpall
Journal:  Stem Cell Investig       Date:  2017-05-25

4.  Overcoming the barriers to umbilical cord blood transplantation.

Authors:  Susan Staba Kelly; Simrit Parmar; Marcos De Lima; Simon Robinson; Elizabeth Shpall
Journal:  Cytotherapy       Date:  2010-04       Impact factor: 5.414

5.  Calcium-Infiltrated Biphasic Hydroxyapatite Scaffolds for Human Hematopoietic Stem Cell Culture.

Authors:  Qinghao Zhang; Jörg C Gerlach; Ian Nettleship; Eva Schmelzer
Journal:  Tissue Eng Part A       Date:  2018-06-04       Impact factor: 3.845

6.  Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice.

Authors:  Lisa J Giassi; Todd Pearson; Leonard D Shultz; Joseph Laning; Kristin Biber; Morey Kraus; Bruce A Woda; Madelyn R Schmidt; Robert T Woodland; Aldo A Rossini; Dale L Greiner
Journal:  Exp Biol Med (Maywood)       Date:  2008-08

Review 7.  Ex vivo expansion of cord blood.

Authors:  S S Kelly; C B S Sola; M de Lima; E Shpall
Journal:  Bone Marrow Transplant       Date:  2009-10-05       Impact factor: 5.483

8.  In vitro expansion of fetal liver hematopoietic stem cells.

Authors:  Rashmi Bhardwaj; Lalit Kumar; Deepika Chhabra; N K Mehra; Atul Sharma; Sujata Mohanty; Vinod Kochupillai
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

9.  Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models.

Authors:  Kazem Zibara; Rima Hamdan; Leila Dib; Steen Sindet-Pedersen; Mohamed Kharfan-Dabaja; Ali Bazarbachi; Marwan El-Sabban
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

Review 10.  Stem cell therapy for autism.

Authors:  Thomas E Ichim; Fabio Solano; Eduardo Glenn; Frank Morales; Leonard Smith; George Zabrecky; Neil H Riordan
Journal:  J Transl Med       Date:  2007-06-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.